Detalles de la búsqueda
1.
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
Oncologist
; 28(9): 827-e822, 2023 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104870
2.
Neoadjuvant Chemoradiation Impacts the Prognostic Effect of Surgical Margin Status in Pancreatic Adenocarcinoma.
Ann Surg Oncol
; 29(1): 354-363, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34114181
3.
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials.
Br J Cancer
; 122(9): 1309-1314, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32152503
4.
A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer.
Invest New Drugs
; 38(3): 821-830, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31338636
5.
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors.
Oncologist
; 24(1): 14-e10, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30115734
6.
Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization.
Radiology
; 282(1): 281-288, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27440733
7.
Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer.
Cancer
; 122(20): 3191-3198, 2016 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27379436
8.
Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study.
Br J Cancer
; 115(5): 564-70, 2016 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27482646
9.
Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer.
Oncologist
; 21(2): 172-7, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26786262
10.
Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.
Acta Oncol
; 55(3): 303-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26581671
11.
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Oncologist
; 20(6): 615-6, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25926352
12.
Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.
J Surg Oncol
; 112(6): 629-33, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26430952
13.
Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter?
Ann Surg Oncol
; 21(2): 662-9, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24276638
14.
Successful imatinib therapy for neuroendocrine carcinoma with activating Kit mutation: a case study.
J Natl Compr Canc Netw
; 12(6): 847-52, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24925195
15.
Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.
J Natl Compr Canc Netw
; 12(2): 235-43, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24586085
16.
Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer.
J Natl Compr Canc Netw
; 12(8): 1123-30, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25099444
17.
Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines.
J Natl Compr Canc Netw
; 12(8): 1083-93, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25099441
18.
Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.
HPB (Oxford)
; 16(1): 34-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23458131
19.
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
Cancer
; 119(8): 1521-7, 2013 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23288663
20.
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy.
JCO Precis Oncol
; 7: e2200648, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085059